Wednesday, September 15, 2010
Education Network to Advance Clinical Trials | Achieving the highest quality cancer care and research through clinical trials
ENACCT was founded in 2004 with support from the Lance Armstrong Foundation. ENACCT is the only national organization devoted solely to identifying, implementing and evaluating innovative community-centered approaches to cancer clinical trials education.
Recent News
Physician Training to Address District’s Low Cancer Clinical Trial Enrollment Rate
Open to Options staff
appeared on the show "Speaking Frankly about Cancer with the Cancer
Support Community" for their April 2010 Broadcast.
"Enhancing Access to Cancer Clinical Trials" article featured in Community View section.
Our Programs
ENACCT and Community-Campus
Partnerships for Health (CCPH) are partners in the federally funded
project, Communities as Partners in Cancer Clinical...
Open to Options, funded as a
cooperative agreement with the Centers for Disease Control and
Prevention, is an innovative pilot project between The...
In 2006, ENACCT launched a unique and ambitious Pilot Education Program (PEP) focused on community engagement and education.
Six free one hour e-learning
courses enabling advocates and community leaders, primary care
providers, and cancer clinical trial staff (CEU provided...
Training & Resources
This program helps clinical research teams improve recruitment and retention, especially among ethnic and racial minorities.
This program empowers community leaders to spread the message about the importance of cancer clinical trials.
This program helps primary care providers explore their important role to increase clinical trials participation.
media CBC News - Health - Cancer survival rates improve slightly - media/public commentaries
Note: see chart for selected cancers (includes ovarian)
Healing Journeys » Cancer as a Turning Point – free conference "Cancer as a Turning Point, From Surviving to Thriving" October
October 9 & 10 - Cancer as a Turning Point, From Surviving to Thriving™
a FREE conference for anyone touched by cancer or other life challenges
San Mateo Performing Arts Center (near San Francisco airport)
www.healingjourneys.org or (800) 423-9882
Health Advisory: Arth-Forth: Unauthorized Herbal Product May Pose Serious Health Risks - Health Canada Advisory 2010-09-15
Advisory
2010-154
September 15, 2010
For immediate release
The issue:
"Arth-Forth" (pictured below), an unauthorized product promoted as an herbal supplement and distributed by Ka Wing Hong Ltd., was tested by Health Canada and found to contain a steroid prescription drug, dexamethasone, that was not declared on the product's labelling. Prescription drugs should only be taken under the supervision of a healthcare practitioner as they may cause serious side effects.Who is affected:
Consumers who may have bought or used "Arth-Forth," particularly people with gastrointestinal ulcers, Cushing's syndrome, severe heart problems, uncontrolled diabetes, uncontrolled high blood pressure, tuberculosis, severe systemic infections (viral, bacterial, fungal), certain eye disorders, and osteoporosis. Retailers who have this product in stock are also affected.NCCN Educational Opportunities - Webinar: An Overview of Gynecologic Malignancies Dept 17th
Educational Events & Programs
NCCN Oncology Case Management Program™ Webinar: An Overview of Gynecologic Malignancies
Friday, September 17, 2010 (On-line)
12:30 PM – 2:00 PM
The Economic Case for Universal Pharmacare | Canadian Centre for Policy Alternatives
Blogger's Note:
the issue of universal pharmacare is old and outstanding/outdated (eg. Romanow Commission/others) but governments have not acted primarily due to political 'infighting'
(full access $$$) FDA Increases Focus on Postmarketing Studies — J. Natl. Cancer Inst.
Note: reference to Avastin/breast cancer
Subscribe to:
Posts
(
Atom
)
Posts
